These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart. Zhang WM, Wang HX, Xia Q, Wong TM. Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688 [Abstract] [Full Text] [Related]
11. Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H. Milanés MV, Rabadan JV, Marin MT, Laorden ML. J Auton Pharmacol; 1998 Dec; 18(6):371-5. PubMed ID: 9915602 [Abstract] [Full Text] [Related]
12. Involvement of calcium in the cardiac depressant actions of a garlic dialysate. Martín N, Bardisa L, Pantoja C, Barra E, Demetrio C, Valenzuela J, Barrios M, Sepúlveda MJ. J Ethnopharmacol; 1997 Jan; 55(2):113-8. PubMed ID: 9032623 [Abstract] [Full Text] [Related]
17. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists. Zahradníková A, Minarovic I, Zahradník I. J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903 [Abstract] [Full Text] [Related]
18. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration. Wilson JL, Nayanar V, Walker JS. Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441 [Abstract] [Full Text] [Related]